I am a Senior Research Fellow and Senior Lecturer of Pharmacy Practice (at UniSA since 2019). I am currently funded by an NHMRC Investigator Grant (EL2: 2021-2025). I am also a qualified pharmacist with experience working as a clinical pharmacist in a large tertiary teaching hospital. I completed my PhD at the University of South Australia in 2014 and was awarded the medal from the School of Pharmacy and Medical Sciences for my thesis work. Following this I was a postdoctoral research associate at the University of Sydney with the NHMRC Cognitive Decline Partnership Centre. I also spent two months as a visiting researcher at the Brocher Foundation (Geneva, Switzerland) in 2014. I also previously held an NHMRC-ARC Dementia Research... Read more
About me
I am a Senior Research Fellow and Senior Lecturer of Pharmacy Practice (at UniSA since 2019). I am currently funded by an NHMRC Investigator Grant (EL2: 2021-2025). I am also a qualified pharmacist with experience working as a clinical pharmacist in a large tertiary teaching hospital. I completed my PhD at the University of South Australia in 2014 and was awarded the medal from the School of Pharmacy and Medical Sciences for my thesis work. Following this I was a postdoctoral research associate at the University of Sydney with the NHMRC Cognitive Decline Partnership Centre. I also spent two months as a visiting researcher at the Brocher Foundation (Geneva, Switzerland) in 2014. I also previously held an NHMRC-ARC Dementia Research Development Fellowship. The first two years of this fellowship were undertaken in Canada with the University of Sydney and the Department of Medicine at Dalhousie University, with the final two years completed at UniSA. I hold affiliate status with the College of Pharmacy, Dalhousie University.
About me
Doctor of Philosophy University of South Australia
Bachelor of Pharmacy University of South Australia
Research
Excludes commercial-in-confidence projects.
Integration and implementation of deprescribing recommendations to reducemedication induced harm, NHMRC - Investigator Grants, 01/01/2021 - 31/12/2025
Optimising quality use of medicines in hospital to improve outcomes in frail older people, NHMRC Targeted Call for Research into Frailty in Hospital Care, 01/01/2020 - 31/12/2024
Optimal Medication Management in Alzheimer's Disease and Dementia, National Institute of Health, 04/01/2019 - 31/01/2022
Consumer and clinician led priority setting for the NNIDR MEDicines and DEMentia (MEDDEM) National Research Action Plan, Australian Association of Gerontology Research Trust, 01/01/2020 - 21/12/2021
Development and implementation of evidence-based deprescribing guidelines to guide person-centred care for people with dementia, NHMRC - ARC Dementia Research Development Fellowship, 01/02/2016 - 28/02/2021
Use of antipsychotic medicines for people aged 65 years and over: A review undertaken for the Australian Commission on Safety and Quality in Health Care, Northern Sydney Area Health Service, 15/04/2019 - 29/11/2019
Research
Research outputs for the last seven years are shown below. To see earlier years visit ORCID or Scopus
Open access indicates that an output is open access.
Year | Output |
---|---|
2020 |
Open access
28
128
|
2019 |
Open access
25
23
56
|
2018 |
Open access
33
36
18
|
2016 |
Open access
90
89
4
|
2016 |
87
78
23
|
Year | Output |
---|---|
2020 |
|
2019 |
|
Year | Output |
---|---|
2022 |
1
2
15
|
2022 |
2
1
16
|
2022 |
16
|
2022 |
Open access
|
2022 |
|
2022 |
|
2022 |
3
10
|
2022 |
Open access
|
2022 |
Open access
|
2022 |
|
2022 |
4
6
|
2022 |
|
2022 |
3
|
2022 |
Open access
|
2022 |
|
2021 |
Open access
11
10
18
|
2021 |
Open access
7
7
27
|
2021 |
Open access
8
7
20
|
2021 |
Open access
2
3
4
|
2021 |
Open access
9
10
13
|
2021 |
Open access
2
3
13
|
2021 |
Open access
9
11
9
|
2021 |
Open access
12
|
2021 |
Open access
14
14
8
|
2021 |
Open access
1
|
2021 |
6
8
|
2021 |
Open access
6
7
10
|
2020 |
Open access
14
16
8
|
2020 |
Open access
12
11
4
|
2020 |
Open access
4
5
7
|
2020 |
Open access
4
4
20
|
2020 |
Open access
9
|
2020 |
Open access
3
23
|
2020 |
Open access
10
9
45
|
2020 |
Open access
12
|
2020 |
Open access
9
8
9
|
2020 |
Open access
6
6
1
|
2020 |
Open access
28
128
|
2020 |
Open access
17
15
17
|
2019 |
4
4
|
2019 |
Open access
12
13
36
|
2019 |
Open access
8
8
7
|
2019 |
Open access
9
11
7
|
2019 |
Open access
8
6
4
|
2019 |
4
3
3
|
2019 |
Open access
5
5
4
|
2019 |
Open access
9
8
8
|
2019 |
Open access
25
23
56
|
2019 |
44
44
102
|
2019 |
Open access
30
30
25
|
2018 |
Open access
13
13
8
|
2018 |
Open access
10
8
9
|
2018 |
Open access
23
20
9
|
2018 |
Open access
33
36
18
|
2018 |
Open access
88
90
329
|
2017 |
Open access
14
9
|
2017 |
Open access
12
11
|
2017 |
Open access
9
7
6
|
2017 |
1
1
|
2017 |
Open access
8
7
53
|
2017 |
Open access
74
69
45
|
2017 |
Open access
119
119
23
|
2017 |
Open access
38
37
30
|
2017 |
Open access
48
47
2
|
2017 |
Open access
4
2
|
2016 |
53
50
31
|
2016 |
|
2016 |
47
49
20
|
2016 |
56
53
17
|
2016 |
23
19
3
|
2016 |
Open access
90
89
4
|
2016 |
87
78
23
|
2016 |
20
16
4
|
2015 |
16
16
|
2015 |
12
12
3
|
2015 |
69
66
7
|
2015 |
Open access
7
2
|
2015 |
59
45
7
|
2015 |
67
57
|
2015 |
Open access
2
4
|
2015 |
Open access
272
250
53
|
2015 |
59
57
3
|
2015 |
Open access
775
693
568
|
2015 |
21
19
|
2014 |
60
54
8
|
2014 |
Open access
177
163
47
|
2014 |
Open access
70
52
15
|
2014 |
Open access
30
31
1
|
2013 |
64
60
|
2013 |
Open access
286
265
43
|
2013 |
154
136
21
|
Year | Output |
---|---|
2020 |
Open access
|
2020 |
Open access
|
2018 |
Open access
|
2018 |
Open access
|
External engagement & recognition
Organisation | Country |
---|---|
Alzheimer’s Australia | AUSTRALIA |
Alzheimers Australia | AUSTRALIA |
Ang Mo Kio-Thye Hua Kwan Hospital | SINGAPORE |
Bloomberg School of Public Health | UNITED STATES |
Bond University | AUSTRALIA |
Bruyère Research Institute | CANADA |
Catholic University of Louvain | BELGIUM |
CDPC | AUSTRALIA |
Chemplus Pty Ltd | AUSTRALIA |
CHU de Limoges | FRANCE |
Cochrane Denmark | DENMARK |
Cochrane Sweden | SWEDEN |
Concordia University | CANADA |
Dalhousie University | CANADA |
Dalhousie University, Faculty of Medicine | CANADA |
Duke University | UNITED STATES |
Flinders University | AUSTRALIA |
Ghent University | BELGIUM |
Hammond Care | AUSTRALIA |
Harvard University | UNITED STATES |
Horizon Health Network | CANADA |
Istituto di Ricerche Farmacologiche Mario Negri | ITALY |
IWK Health Centre | CANADA |
Johns Hopkins | UNITED STATES |
Johns Hopkins Community Physicians | UNITED STATES |
Johns Hopkins University | UNITED STATES |
Johns Hopkins University Bloomberg | UNITED STATES |
Kaiser Permanente | UNITED STATES |
Karolinska Institute | SWEDEN |
Khoo Teck Puat Hospital | SINGAPORE |
Laval University | CANADA |
Leiden University | NETHERLANDS |
Limoges University | FRANCE |
Liverpool hospital | UNITED KINGDOM |
Mario Negri Institute for Pharmacological Research | ITALY |
McGill University | CANADA |
Monash University | AUSTRALIA |
Monash University Malaysia | MALAYSIA |
National Healthcare Group Pharmacy | SINGAPORE |
National University Hospital | SINGAPORE |
Newcastle University, United Kingdom | UNITED KINGDOM |
Nova Scotia Health Authority | CANADA |
Ospedale Maggiore Policlinico | ITALY |
Princess Alexandra Hospital | AUSTRALIA |
Queensland University of Technology | AUSTRALIA |
Repatriation General Hospital | AUSTRALIA |
Resthaven Incorporated | AUSTRALIA |
Resthaven Limited | AUSTRALIA |
Royal Adelaide Hospital | AUSTRALIA |
Royal College of Surgeons | IRELAND |
Royal College of Surgeons in Ireland | IRELAND |
Royal North Shore Hospital | AUSTRALIA |
Royal Prince Alfred Hospital | AUSTRALIA |
Singapore General Hospital | SINGAPORE |
Sydney Pharmacy School | AUSTRALIA |
Tan Tock Seng Hospital | MALAYSIA |
Université Laval | CANADA |
University and University Hospital of Zurich | SWITZERLAND |
University of Adelaide | AUSTRALIA |
University of Auckland | NEW ZEALAND |
University of Bari | ITALY |
University of Basel | SWITZERLAND |
University of Bern | SWITZERLAND |
University of Bristol | UNITED KINGDOM |
University of British Columbia | CANADA |
University of California San Francisco | UNITED STATES |
University of Colorado | UNITED STATES |
University of Geneva | SWITZERLAND |
University of Groningen | NETHERLANDS |
University of Huddersfield | UNITED KINGDOM |
University of Illinois at Urbana-Champaign | UNITED STATES |
University of Ioannina | GREECE |
University of Kentucky | UNITED STATES |
University of Lausanne | SWITZERLAND |
University of Leeds | UNITED KINGDOM |
University of Milan | ITALY |
University of Montreal | CANADA |
University of New South Wales | AUSTRALIA |
University of Newcastle | AUSTRALIA |
University of North Texas Health Science Center | UNITED STATES |
University of Otago | NEW ZEALAND |
University of Ottawa | CANADA |
University of Quebec | CANADA |
University of Queensland | AUSTRALIA |
University of South Australia | AUSTRALIA |
University of Southern Denmark | DENMARK |
University of Sydney | AUSTRALIA |
University of Technology Sydney | AUSTRALIA |
University of Texas Arlington | UNITED STATES |
University of Toronto | CANADA |
University of Washington | UNITED STATES |
University of Waterloo | CANADA |
University of Western Australia | AUSTRALIA |
University of Wisconsin-Madison | UNITED STATES |
UNSW Australia | AUSTRALIA |
US Department of Veterans Affairs | UNITED STATES |
Utrecht University | NETHERLANDS |
External engagement & recognition
Engagement/recognition | Year |
---|---|
Dementia Research Development FellowshipNational Health and Medical Research Council (NHMRC) Australian Research Council (ARC) |
2020 |
Executive Committee Member and Chair of Public Engagement SubcommitteeAustralian Deprescribing Network (ADeN) |
2020 |
Invited SpeakerAustralian Association of Consultant Pharmacy (AACP) 16th Annual Consultant Clinical Pharmacy Seminar |
2020 |
Invited to provide input on: Baseline report on Quality Use of Medicines and Medicines Safety ¿ÛÒ Discussion paper for public consultationAustralian Commission on Safety and Quality in Health Care |
2020 |
MemberSociety of Hospital Pharmacists of Australia (SHPA) |
2020 |
MemberAustralasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) |
2020 |
MemberAustralasian Pharmaceutical Science Association (APSA) |
2020 |
MemberAustralian Association of Gerontology (AAG) |
2020 |
Member of the Investigator Development Core and Expert ConsultantUnited States Deprescribing Research Network (USDeN) |
2020 |
Steering Committee MemberGuidelines International Network (G.I.N.) Australia and New Zealand (ANZ) |
2020 |
Best 'Rapid Fire' Oral PresentationTheo Murphy Australian Frontiers of Science Redefining Health Ageing Together (Australian Academy of Science) Conference |
2019 |
Dementia Research Development FellowshipNational Health and Medical Research Council (NHMRC) Australian Research Council (ARC) |
2019 |
Executive Committee Member and Chair of Public Engagement SubcommitteeAustralian Deprescribing Network (ADeN) |
2019 |
Founding MemberAustralian Deprescribing Network (ADeN) |
2019 |
Invited Speaker, Annual Scientific MeetingAmerican Geriatrics Society (AGS) |
2019 |
MemberGerontological Society of America |
2019 |
MemberRoyal North Shore Hospital Scientific Staff Council |
2019 |
MemberNHMRC National Institute for Dementia Research |
2019 |
MemberAustralasian Pharmaceutical Science Association (APSA) |
2019 |
MemberSydney Dementia Network (dementia) |
2019 |
MemberAustralian Association of Gerontology (AAG) |
2019 |
MemberSociety of Hospital Pharmacists of Australia |
2019 |
MemberAustralasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) |
2019 |
Member of the Investigator Development Core and Expert ConsultantUnited States Deprescribing Research Network (USDeN) |
2019 |
Plenary speakerHouston Medication Safety Symposium |
2019 |
Plenary Speaker, Annual MeetingAustralian Deprescribing Network (ADeN) |
2019 |
Early Achievement Award for Women: 2018Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) |
2018 |
Expert Consultant on National Report on Polypharmacy: Medication Overload: How the drive to prescribe is harming older AmericansLown Institute |
2018 |
Founding MemberAustralian Deprescribing Network (ADeN) |
2018 |
Invited SpeakerCanadian Frailty Network Conference, Canada |
2018 |
Invited SpeakerSwiss Society of Internal Medicine Annual Meeting, Switzerland |
2018 |
MemberGerontological Society of America |
2018 |
MemberRoyal North Shore Hospital Scientific Staff Council |
2018 |
MemberNHMRC National Institute for Dementia Research |
2018 |
MemberAustralasian Pharmaceutical Science Association (APSA) |
2018 |
MemberSydney Dementia Network (dementia) |
2018 |
MemberSociety of Hospital Pharmacists of Australia |
2018 |
MemberAustralasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) |
2018 |
Organising Committee Member, Invited Presenter, Panel Member and Workshop FacilitatorEvidence-Based Deprescribing Guideline Symposium, Canada |
2018 |
Dementia Research Development FellowshipNational Health and Medical Research Council (NHMRC) Australian Research Council (ARC) |
2017 |
Founding MemberAustralian Deprescribing Network (ADeN) |
2017 |
Invited SpeakerNorthwood Research Symposium, Canada |
2017 |
Invited Speaker and Panel MemberPharmacy Association of Nova Scotia Annual Conference, Canada |
2017 |
MemberGerontological Society of America |
2017 |
MemberRoyal North Shore Hospital Scientific Staff Council |
2017 |
MemberNHMRC National Institute for Dementia Research |
2017 |
MemberAustralasian Pharmaceutical Science Association (APSA) |
2017 |
MemberSociety of Hospital Pharmacists of Australia |
2017 |
MemberAustralasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) |
2017 |
Symposium Chair and Presenter21st IAGG World Congress of Gerontology and Geriatrics |
2017 |
Best Oral Presentation (rapid fire presentations)Australian National Dementia Forum, Brisbane |
2016 |
Dementia Research Development FellowshipNational Health and Medical Research Council (NHMRC) Australian Research Council (ARC) |
2016 |
Emerging Health Researcher Award Finalist: 2016Bupa Health Foundation |
2016 |
Founding MemberAustralian Deprescribing Network (ADeN) |
2016 |
Invited SpeakerAustralasian Pharmaceutical Science Association Annual Conference, Sydney |
2016 |
MemberGerontological Society of America |
2016 |
MemberRoyal North Shore Hospital Scientific Staff Council |
2016 |
MemberNHMRC National Institute for Dementia Research |
2016 |
MemberAustralasian Pharmaceutical Science Association (APSA) |
2016 |
MemberSociety of Hospital Pharmacists of Australia |
2016 |
MemberAustralasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) |
2016 |
Founding MemberAustralian Deprescribing Network (ADeN) |
2015 |
Invited Session ChairAustralian Pharmaceutical Sciences Association (APSA), Australian Society of Clinical and Experimental Pharmacology and Toxicology (ASCEPT) Joint Meeting |
2015 |
Invited SpeakerMedicines Management, 41st SHPA National Conference, Melbourne |
2015 |
MemberGerontological Society of America |
2015 |
MemberRoyal North Shore Hospital Scientific Staff Council |
2015 |
MemberSociety of Hospital Pharmacists of Australia |
2015 |
MemberAustralasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) |
2015 |
Workshop ConvenorAustralian Deprescribing Network Annual Workshop, Sydney |
2015 |
Early Career Research Award Presentation (Finalist)New Horizons (Kolling Institute, NSW) |
2014 |
Founding MemberAustralian Deprescribing Network (ADeN) |
2014 |
Invited SpeakerDeprescribing Workshop, Australian Deprescribing Network, Brisbane |
2014 |
MemberGerontological Society of America |
2014 |
MemberRoyal North Shore Hospital Scientific Staff Council |
2014 |
MemberSociety of Hospital Pharmacists of Australia |
2014 |
MemberAustralasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) |
2014 |
MemberSociety of Hospital Pharmacists of Australia |
2013 |
Invited SpeakerAustralian Association of Consultant Pharmacists meeting, Pharmacy Congress Australia |
2012 |
MemberSociety of Hospital Pharmacists of Australia |
2012 |
MemberSociety of Hospital Pharmacists of Australia |
2011 |
MemberSociety of Hospital Pharmacists of Australia |
2010 |
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
Assessment of adherence and assessing drug concentration effect relationships in patients with rheumatoid arthritis and scleroderma. | Current |
Comparison of different methods to assess adherence to weekly methotrexate and hydroxychloroquine | Current |
Developing strategies to promote the use of treat to target strategies with conventional synthetic disease modifying anti-rheumatic drugs in patients with early rheumatoid arthritis | Current |